Top 10 Fast-growings companies in Carbonic anhydrase inhibitor by Most Patent Filing In 3 Years in the United States in 2019 – Discovery

Free Trial

The Carbonic anhydrase inhibitor top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filing In 3 Years Carbonic anhydrase inhibitor Fast-growings in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Ranking Year:

Region:

Ranking:

1	Graybug Vision, Inc.	United States	Medicine,Health care,Glaucoma, ...[+2]	Patent: 7
2	Ocuphire Pharma, Inc.	Michigan, United States	OPHTHALMIC DISORDERS,Glaucoma,Eye drop, ...[+2]	Patent: 5
3	Endocyte, Inc.	Indiana, United States	Medicine,Health care,Drug, ...[+2]	Patent: 4
4	Ocugen, Inc.	Pennsylvania, United States	Medicine,Health care,Biopharmaceutical, ...[+2]	Patent: 3
5	The Johns Hopkins University	United States	History of the United States,Bequest,Medicine, ...[+2]	Patent: 2
6	Purdue Research Foundation	Indiana, United States	Financial asset,Technology transfer,Incubation, ...[+2]	Patent: 2
7	VIVUS, Inc.	California, United States	Medicine,Health care,Obesity, ...[+2]	Patent: 1
8	University Hospitals Cleveland Medical Center	Ohio, United States	Primary care physician,Health care,Hospitality industry, ...[+2]	Patent: 1
9	New York University	New York, United States	Journalism,Professional studies,Medicine, ...[+2]	Patent: 1
10	The University of Texas at Austin	Texas, United States	Undergraduate education,Career development,Association (object-oriented programming), ...[+2]	Patent: 1